Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Preface xvii
Section 1 Epidemiology and classification of childhood epilepsies 1
Section editor: Phillip L. Pearl
1 Epidemiology and common comorbidities of epilepsy in childhood 3
Jay Salpekar, Matthew Byrne, and Georgann Ferrone
1.1 Epidemiology 3
1.2 Incidence and prevalence 4
1.3 Gender and age 4
1.4 Classification 5
1.5 Febrile seizures 6
1.6 Etiology 6
1.7 Psychiatric comorbidity 7
1.8 Psychological and psychosocial stress related to chronic disease 7
1.9 Psychiatric symptoms related to medication side effects 8
1.10 Psychiatric comorbidity related to epilepsy pathophysiology 8
1.11 Attention-deficit/hyperactivity disorder (ADHD) 9
1.12 Anxiety 10
1.13 Depression 11
1.14 Intellectual and developmental disabilities (IDD) 12
1.15 Conclusion 12
References 13
2 Classification and definition of seizures and epilepsy syndromes in childhood 17
Susan E. Combs and Phillip L. Pearl
2.1 Introduction 17
2.2 Purpose and goals of definitions and classification 17
2.3 Systems of classification and definitions 18
2.4 Seizures 18
2.5 Generalized seizures 19
2.6 Focal seizures 22
2.7 Syndromes 23
2.8 Specific age-related epilepsy syndromes 25
2.9 Future directions 34
Acknowledgements 34
References 34
3 Initiating and withdrawing medical management 37
David T. Hsieh and Bhagwan Indur Moorjani
3.1 Initiating medical management 37
3.2 The chances of seizure recurrence after the first unprovoked seizure 39
3.3 Seizure recurrence 42
3.4 The possible adverse effects of seizure recurrence 42
3.5 The risks of initiating antiepileptic drug therapy 44
3.6 The benefits of initiating antiepileptic drug therapy 45
3.7 How to initiate treatment with antiepileptic drugs 45
3.8 Special circumstances 48
3.9 Summary: initiating medical management 48
3.10 Withdrawing medical management 49
3.11 The long-term prognosis of childhood-onset epilepsy 50
3.12 When to consider discontinuing antiepileptic drug therapy 51
3.13 Risk factors for seizure recurrence after discontinuation 51
3.14 The risks of discontinuing antiepileptic drug therapy 54
3.15 The benefits of discontinuing antiepileptic drug therapy 55
3.16 How to discontinue antiepileptic drugs 55
3.17 Special circumstances 55
3.18 Summary: withdrawing medical management 56
3.19 Disclaimer 57
References 57
4 Common genetic and neurocutaneous disorders in childhood epilepsy 59
Dewi Frances T. Depositario-Cabacar, William McClintock, and Tom Reehal
4.1 Idiopathic epilepsies 60
4.2 Symptomatic epilepsies 63
4.3 Epilepsy in common chromosomal abnormalities 63
4.4 Epilepsy in metabolic and mitochondrial disorders 65
4.5 Epilepsy in malformations of cortical development 66
4.6 Neurocutaneous disorders 67
4.7 Summary 70
References 70
Section 2 Diagnostic evaluation of childhood epilepsies 73
Section editor: David F. Clarke
5 Evaluating the child with seizures 75
Kristen Park and Susan Koh
5.1 Emergent diagnosis and management 76
5.2 Subsequent evaluation 79
5.3 Additional neurodiagnostic evaluation 84
References 87
6 The use of EEG in the diagnosis of childhood epilepsy 90
David F. Clarke
6.1 Technical aspects of the EEG 91
6.2 Methods used to increase EEG yield 91
6.3 When should an EEG be ordered? 92
6.4 EEG findings in epilepsy and epilepsy syndromes 93
6.5 Neonatal EEGs 94
6.6 The EEG in focal epilepsy 96
6.7 The EEG of generalized epilepsy 99
6.8 Specific disease-related epilepsy syndromes 104
6.9 Conclusion 105
References 105
7 Imaging of pediatric epilepsy 107
Asim F. Choudhri
7.1 Introduction 107
7.2 Imaging considerations 107
7.3 Congenital malformations 117
7.4 Neoplasms 124
7.5 Acquired/idiopathic abnormalities 126
References 127
8 Non-epileptic paroxysmal events of childhood 129
Sucheta M. Joshi
8.1 Introduction 129
8.2 Breath-holding spells 130
8.3 Parasomnias 131
8.4 Benign paroxysmal positional vertigo of childhood 133
8.5 Syncope 134
8.6 Paroxymal non-epileptic events (PNEs) with a psychiatric or behavioral basis 134
8.7 Hyperekplexia 136
8.8 Alternating hemiplegia of childhood 136
8.9 Movement disorders 137
8.10 Sandifer syndrome 138
8.11 Conclusion 138
References 139
Section 3 Principles of treatment 143
Section editor: James W. Wheless
9 Pharmacology of antiepileptic drugs 145
James W. Wheless
9.1 Pharmacokinetics 146
9.2 Pharmacogenomics 155
References 157
10 Therapeutic efficacy of antiepileptic drugs 159
10.1 Efficacy-based treatment guidelines 160
10.2 Antiepileptic drug selection based on specific pediatric epilepsy syndromes 164
10.3 Influence of comorbidities in children with epilepsy 171
10.4 Conclusions 172
References 172
11 Adverse effects of antiepileptic drugs 175
11.1 Introduction 175
11.2 Specific drugs 179
11.3 At-risk profiles and monitoring 189
References 191
12 Vagus nerve stimulation therapy and epilepsy surgery 193
Kate Van Poppel and James W. Wheless
12.1 Vagus nerve stimulation 195
12.2 Epilepsy surgery 203
12.3 Conclusions 215
References 215
13 Dietary therapies to treat epilepsy 219
13.1 History 220
13.2 Efficacy 221
13.3 Mechanism of action 228
13.4 Selection of candidates for the diet 232
13.5 Initiation and maintenance 234
13.6 Complications 236
13.7 The ketogenic diet in the twenty-first century 239
References 239
Resources 240
Websites 241
Section 4 Generalized seizures and generalized epilepsy syndromes 243
Section editor: Amy L. McGregor
14 Idiopathic generalized epilepsies 245
Amy L. McGregor
14.1 Clinical features 246
14.2 Natural history 248
14.3 Genetics 248
14.4 Treatment 248
14.5 Classification 249
14.6 Myoclonic epilepsy in infancy 249
14.7 Childhood absence epilepsy (CAE) 250
14.8 Juvenile absence epilepsy (JAE) 252
14.9 Juvenile myoclonic epilepsy (JME) 254
14.10 Epilepsy with generalized tonic-clonic seizures alone (IGE-GTCs) 256
14.11 Epilepsy with myoclonic absence 257
14.12 Epilepsy with myoclonic-atonic seizures/Doose syndrome 258
14.13 Febrile seizures plus (FS+) 259
14.14 Eyelid myoclonia with absences (EMA)/Jeavons syndrome 260
14.15 Summary 262
References 264
15 Cryptogenic and symptomatic generalized epilepsies: epilepsies with encephalopathy 267
Karen Keough
15.1 Neonatal-onset epilepsies with encephalopathy 268
15.2 Infantile-onset epilepsies with encephalopathy 270
15.3 Epilepsies with encephalopathy with onset later in infancy 275
15.4 Epilepsies with encephalopathy with onset after infancy 277
15.5 Continuous spike wave of sleep (CSWS) and Landau-Kleffner
syndrome (LKS) 279
References 280
Section 5 Partial-onset seizures and localization-related epilepsy syndromes 283
16 Idiopathic partial epilepsies 285
Freedom F. Perkins Jr
16.1 Benign infantile seizures 286
16.2 Benign childhood epilepsy with centrotemporal spikes 287
16.3 Childhood occipital epilepsy (Panayiotopoulos type) 289
16.4 Late-onset childhood occipital epilepsy (Gastaut type) 292
References 294
17 Cryptogenic and symptomatic partial epilepsies 296
Stephen Fulton
17.1 Etiology 296
17.2 Seizure phenomena 297
17.3 Temporal lobe epilepsy 297
17.4 Extratemporal epilepsy 303
17.5 Occipital lobe epilepsy 306
17.6 Parietal lobe epilepsy 307
17.7 Hypothalamic hamartoma 307
17.8 Other localizing and lateralizing signs 308
References 309
Section 6 Epilepsies relative to age, etiology, or duration 311
Section editor: Yu-Tze Ng
18 Neonatal seizures 313
Eric V. Hastriter
18.1 Significance of neonatal seizures 313
18.2 Pathophysiology of neonatal seizures 314
18.3 Classification and clinical features of neonatal seizures 316
18.4 Electrographic seizures 317
18.5 Monitoring and recording 317
18.6 Etiology of neonatal seizures 321
18.7 Metabolic causes for neonatal seizures 323
18.8 Inborn errors of metabolism 323
18.9 Treatment 327
18.10 Chronic postnatal epilepsy and the need for long-term treatment 328
18.11 Potential adverse effects of antiepileptic drugs on the immature CNS 329
18.12 Conclusion 329
References 330
19 Febrile seizures 333
Marie Francisca Grill
19.1 Introduction 333
19.2 Definition 333
19.3 Incidence and prevalence 334
19.4 Pathophysiology 334
19.5 Prognosis 334
19.6 Initial evaluation and management 335
19.7 Long-term management 338
19.8 Management in practice 341
19.9 Genetics 342
19.10 Parent counseling 343
19.11 Conclusion 344
References 344
20 Status epilepticus in childhood 346
Yu-Tze Ng and Rama Maganti
20.1 Definition 346
20.2 Epidemiology 349
20.3 Pathophysiology 349
20.4 Etiology 350
20.5 Diagnosis and investigations 351
20.6 EEG patterns in status epilepticus 352
20.7 Treatment 356
20.8 Prognosis 359
References 359
Index 365
1
Epidemiology and common comorbidities of epilepsy in childhood
Jay Salpekar1, Matthew Byrne2 and Georgann Ferrone1
1Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, Washington, DC, USA
2Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Epilepsy is a common illness in childhood, and the epidemiology has been well described. However, epilepsy is also complex and controversial in terms of optimal methods for diagnosis and treatment. Classification schemes for seizures have been refined over the years and improved treatment options have allowed better outcomes for children with epilepsy. Understanding of comorbidity, particularly psychiatric comorbidity, has also improved over recent years, yet in many cases it is difficult to resolve whether psychiatric illness is coincidental or associated with the underlying seizure disorder. This chapter addresses the incidence and prevalence of childhood epilepsy and strategies for identifying and managing common psychiatric comorbidities.
1.1 Epidemiology
An epileptic seizure is defined as the clinical manifestation of abnormal or excessive discharge of neurons in the brain [1]. Epilepsy is defined as recurrent seizures, specifically two or more seizures separated by 24 hours but within 18 months of one another [1,2]. This common consensus is based on observations that children who experience one seizure have an approximately 50% chance of recurrence within 2 years [3,4]. It is important to note that febrile seizures are not included in most epidemiological studies of epilepsy.
Population-based studies concerning seizures and epilepsy have been done in numerous communities around the world. Although many international studies of prevalence are based on small communities, the results can be extrapolated to reflect wider regions of the world. In the United States, there are approximately 2.3 million people diagnosed with epilepsy, which reflects an incidence of approximately 1% of the population [5]. The pediatric population, however, has a higher prevalence of epilepsy; 4–10% of children will experience a seizure before the age of 16. Thus, a working knowledge of epilepsy is very important for primary and specialty clinicians in pediatrics, as well as for pediatric neurologists [6].
1.2 Incidence and prevalence
In the general population, the incidence of epilepsy is reported at between 40 and 70 cases per 100 000 [7]. The incidence of childhood epilepsy has been reported to be 82.2 per 100 000 children, markedly higher than that of the overall population [8]. A meta-analysis of over 40 epidemiological studies found that the highest incidence of epilepsy occurs in childhood and in the geriatric population. Interestingly, the incidence of epilepsy has been decreasing over the past 50 years. This decrease in incidence could be explained by more stringent and/or universally followed diagnostic criteria or perhaps from a decrease in exposure to epilepsy risk factors [8].
The overall number of children affected by epilepsy, or the prevalence of the disease, is higher than the incidence because of the chronic nature of epilepsy. A significant variation in prevalence is found in international epidemiology studies [9-12]. In the United States, epilepsy prevalence averages 3.83 per 1000 children, while in northern Tanzania, it is 7.39 per 1000 [13,14]. This discrepancy may result from a variety of factors including possible misclassification of a single seizure as epilepsy. Environmental factors, access to healthcare, and different methods of reporting may also account for some of the variability. The prevalence of epilepsy in varying regions across the world is described in Table 1.1.
Table 1.1 International epidemiology studies.
1.3 Gender and age
Studies have consistently found that males are diagnosed with epilepsy more often than females [18]. While the difference between the genders is slight, this trend holds true for most populations [13]. Although there are exceptions to this trend, they are rarely statistically significant in children [10,11]. Analysis of prevalence among children of varying ages found that epilepsy was most common in children under the age of 5, with a gradual decline in occurrence in older age groups [15]. Figure 1.1 demonstrates the peak of prevalence at a young age and a gradual decrease in children as they age.
FIGURE 1.1 Graph showing prevalence of epilepsy (per 1000) in children by year from age 1 to 19 [16].
1.4 Classification
When studying the epidemiology of epilepsy, means of classification must be clarified to ensure uniformity in standards. Since 1909, the International League Against Epilepsy (ILAE) has worked toward identifying, studying, and classifying all variations of seizure disorders. Epilepsy syndromes can be classified as localization-related or generalized. The syndromes are determined by multiple criteria, with particular emphasis on seizure type as well as associated patient characteristics such as age of onset, comorbidities including neurodevelopmental status, presence of associated family history, and identification of an underlying etiology [1]. Distinguishing characteristics of seizure types can range from loss or modification of consciousness and responsiveness, along with total or partial motor control impairment [2].
A 40-year detailed study done in Rochester, Minnesota, found that partial seizures are the most prevalent, followed by generalized tonic-clonic, absence, and then myoclonic. Details for prevalence are represented in Figure 1.2 [13].
FIGURE 1.2 Bar graph of relative prevalence of adolescent seizure etiologies (per 1000) [13].
1.5 Febrile seizures
Febrile seizures are a common seizure disorder for children under the age of 3 years. Between 2% and 4% of children will suffer from one febrile seizure, and only one-third of these children will have a second seizure [18]. Most importantly, a febrile seizure will not always lead to epilepsy. Between 2% and 10% of children who experience one febrile seizure will develop epilepsy [19].
1.6 Etiology
Most cases of epilepsy are of unknown etiology [12]. Recent guidelines have identified three main classifications of epilepsy etiologies: Genetic, metabolic/structural, and idiopathic/unknown [2]. Genetic disorders include diseases due to a known genetic defect in which seizures are the main manifestation of the disease. Seizures of metabolic/structural etiology can be those epilepsies attributed to lesions, which are often a result of head trauma, central nervous system (CNS) infection, or tumor [4]. Epilepsy of unknown etiology represents the most common designation for epilepsy in childhood.
1.7 Psychiatric comorbidity
Psychiatric and psychological complications are commonly associated with pediatric epilepsy [20-23]. In pediatrics, the classic Isle of Wight epidemiology study reports psychiatric illness present in 16% of patients with chronic medical illness; however, if that illness happened to be epilepsy, the psychiatric comorbidity was 29% [24]. Subsequent studies have confirmed an overrepresentation of psychiatric illness associated with epilepsy as compared to many other chronic medical illnesses. Some studies report a two- or three-fold greater prevalence of psychiatric illness associated with epilepsy as compared to diabetes or asthma [25,26]. Of particular concern is evidence showing an overrepresentation of epilepsy among children and adolescents hospitalized for suicide attempts [27]. Despite numerous reports confirming high levels of comorbidity, many children and adolescents with epilepsy do not receive treatment for psychiatric illness [28]. In many cases, the psychiatric comorbidity may be more impairing to quality of life for children and families than the seizures themselves [29].
This consistently high level of psychiatric comorbidity suggests that epilepsy is a complicated illness that may have neuropsychiatric symptoms well beyond discrete seizures. However, the etiology of psychiatric comorbidity in children and adolescents with epilepsy is still controversial. Psychiatric illness may be difficult to isolate as an independent disorder in the context of seizure events. Some symptoms may be clearly related to ictal or postictal phenomena, but more often, psychiatric symptoms occur during interictal time periods and may be viewed as only indirectly related to epilepsy pathophysiology [30]. Classic views of forced normalization, in which psychiatric symptoms increase when the epilepsy stabilizes (the EEG “normalizes”), complicate conceptualization of comorbidity in relation to epilepsy pathophysiology [31]. Nevertheless, the frequent occurrence of psychiatric disorder has raised awareness of the need for an interdisciplinary approach to management of epilepsy [32,33]. The existing literature tends to focus upon one of three potential explanations for psychiatric comorbidity: symptoms related to psychosocial stress of chronic disease; symptoms related to medication side effects; and symptoms directly related to epilepsy pathophysiology.
1.8 Psychological and psychosocial stress related to chronic disease
Studies of health-related quality of life consistently report marked psychosocial stress for...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.